Bailard Inc. purchased a new position in shares of Nature's Sunshine Products, Inc. (NASDAQ:NATR - Free Report) during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm purchased 20,600 shares of the company's stock, valued at approximately $302,000. Bailard Inc. owned about 0.11% of Nature's Sunshine Products at the end of the most recent reporting period.
Several other hedge funds also recently modified their holdings of the company. Proficio Capital Partners LLC acquired a new stake in shares of Nature's Sunshine Products during the 4th quarter worth about $200,000. JPMorgan Chase & Co. boosted its stake in shares of Nature's Sunshine Products by 24.3% during the 3rd quarter. JPMorgan Chase & Co. now owns 34,633 shares of the company's stock worth $472,000 after purchasing an additional 6,769 shares during the last quarter. Franklin Resources Inc. boosted its stake in shares of Nature's Sunshine Products by 4.3% during the 3rd quarter. Franklin Resources Inc. now owns 20,744 shares of the company's stock worth $270,000 after purchasing an additional 856 shares during the last quarter. Barclays PLC boosted its stake in shares of Nature's Sunshine Products by 51.8% during the 3rd quarter. Barclays PLC now owns 35,602 shares of the company's stock worth $485,000 after purchasing an additional 12,152 shares during the last quarter. Finally, Jacobs Levy Equity Management Inc. boosted its stake in shares of Nature's Sunshine Products by 7.7% during the 3rd quarter. Jacobs Levy Equity Management Inc. now owns 67,258 shares of the company's stock worth $916,000 after purchasing an additional 4,820 shares during the last quarter. 79.40% of the stock is owned by institutional investors and hedge funds.
Nature's Sunshine Products Stock Performance
Nature's Sunshine Products stock traded up $0.05 during trading on Friday, reaching $14.57. The company had a trading volume of 19,654 shares, compared to its average volume of 47,955. Nature's Sunshine Products, Inc. has a 12-month low of $10.81 and a 12-month high of $21.72. The stock's 50 day moving average price is $14.43 and its two-hundred day moving average price is $14.35. The firm has a market capitalization of $269.20 million, a price-to-earnings ratio of 16.56 and a beta of 0.91.
Nature's Sunshine Products Company Profile
(
Free Report)
Nature's Sunshine Products, Inc, a natural health and wellness company, manufactures and sells nutritional and personal care products in Asia, Europe, North America, Latin America, and internationally. It offers general health products related to blood sugar support, bone health, cellular health, cognitive function, joint health, mood, sexual health, sleep, sports and energy, and vision.
Further Reading
Before you consider Nature's Sunshine Products, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Nature's Sunshine Products wasn't on the list.
While Nature's Sunshine Products currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering when you'll finally be able to invest in SpaceX, Starlink, or X.AI? Enter your email address to learn when Elon Musk will let these companies finally IPO.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
